GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tikun Olam Cannbit Pharmaceuticals Ltd (XTAE:TKUN) » Definitions » Debt-to-Equity

Tikun Olam Cannbit Pharmaceuticals (XTAE:TKUN) Debt-to-Equity : 0.49 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Tikun Olam Cannbit Pharmaceuticals Debt-to-Equity?

Tikun Olam Cannbit Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪13.61 Mil. Tikun Olam Cannbit Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪6.46 Mil. Tikun Olam Cannbit Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₪40.87 Mil. Tikun Olam Cannbit Pharmaceuticals's debt to equity for the quarter that ended in Dec. 2023 was 0.49.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Tikun Olam Cannbit Pharmaceuticals's Debt-to-Equity or its related term are showing as below:

XTAE:TKUN' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.92   Med: 0.15   Max: 39.5
Current: 0.49

During the past 12 years, the highest Debt-to-Equity Ratio of Tikun Olam Cannbit Pharmaceuticals was 39.50. The lowest was -0.92. And the median was 0.15.

XTAE:TKUN's Debt-to-Equity is ranked worse than
64.48% of 853 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs XTAE:TKUN: 0.49

Tikun Olam Cannbit Pharmaceuticals Debt-to-Equity Historical Data

The historical data trend for Tikun Olam Cannbit Pharmaceuticals's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tikun Olam Cannbit Pharmaceuticals Debt-to-Equity Chart

Tikun Olam Cannbit Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.50 0.17 0.12 0.13 0.16

Tikun Olam Cannbit Pharmaceuticals Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.19 0.16 0.42 0.49

Competitive Comparison of Tikun Olam Cannbit Pharmaceuticals's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Tikun Olam Cannbit Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tikun Olam Cannbit Pharmaceuticals's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tikun Olam Cannbit Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Tikun Olam Cannbit Pharmaceuticals's Debt-to-Equity falls into.



Tikun Olam Cannbit Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Tikun Olam Cannbit Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Tikun Olam Cannbit Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tikun Olam Cannbit Pharmaceuticals  (XTAE:TKUN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Tikun Olam Cannbit Pharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Tikun Olam Cannbit Pharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Tikun Olam Cannbit Pharmaceuticals (XTAE:TKUN) Business Description

Traded in Other Exchanges
N/A
Address
The Fourteenth, Tel Aviv, ISR
Tikun Olam Cannbit Pharmaceuticals Ltd is engaged in the business of growing and marketing medical cannabis.

Tikun Olam Cannbit Pharmaceuticals (XTAE:TKUN) Headlines

No Headlines